Unitary Tract Infection Treatment: When to Use What Agents including Beta-lactam Combination Agents

Arsheena Yassin; Keith S Kaye; Tanaya Bhowmick

doi:10.1016/j.idc.2024.03.007

Unitary Tract Infection Treatment: When to Use What Agents including Beta-lactam Combination Agents

Infect Dis Clin North Am. 2024 Jun;38(2):295-310. doi: 10.1016/j.idc.2024.03.007. Epub 2024 Apr 8.

Authors

Arsheena Yassin¹, Keith S Kaye², Tanaya Bhowmick³

Affiliations

¹ Department of Pharmacy, Robert Wood Johnson University Hospital, 1 Robert Wood Johnson Place, New Brunswick, NJ 08901, USA. Electronic address: [email protected].
² Division of Infectious Disease, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, CAB 7136, MPH, New Brunswick, NJ 08901, USA.
³ Division of Infectious Disease, Rutgers Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, MEB 362, New Brunswick, NJ 08901, USA.

PMID: 38594140
DOI: 10.1016/j.idc.2024.03.007

Abstract

In this study, the authors review antibiotic treatment options for both acute uncomplicated and complicated urinary tract infection (UTI). In addition, they also review regimens used in the setting of drug-resistant pathogens including vancomycin resistant Enterococcus, extended spectrum beta-lactamase (ESBL) producing Enterobacterals, carbapenem-resistant Enterobacterals and carbapenem-resistant Pseudomonas, which are encountered with increasing frequency.

Keywords: Antimicrobial resistance; Pyelonephritis; Urinary tract infection.

Publication types

Review

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Drug Therapy, Combination
Humans
Urinary Tract Infections* / drug therapy
Urinary Tract Infections* / microbiology
beta-Lactams* / therapeutic use

Substances

Anti-Bacterial Agents
beta-Lactams